EGFR and cancer: The expression of TBXT is also increasingly reported in other cancers of the lung, small intestine, stomach, kidney, bladder, uterus, ovary and testis: its expression correlates with epithelial-to-mesenchymal transition (EMT), maintenance of an undifferentiated state and the resistance of lung cancer cells to EGFR inhibition (Roselli et al., 2012).